Clinical trial
Geodon in Weight Loss Study for Bipolar Disorders
NCT00472641 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00472641 |
|---|---|
| Title | Geodon in Weight Loss Study for Bipolar Disorders |
| Official title | Adjunctive Ziprasidone in Overweight and Obese Patients With Bipolar Disorder |
| Lead sponsor | Stanford University, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Ziprasidone/Geodon |
| Enrollment | 25 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | May 14, 2007 |
| Last update posted | May 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: